- $1.52bn
- $1.29bn
- $914.53m
- 96
- 58
- 51
- 77
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 910 | 892 | 831 | 856 | 915 |
Cost of Revenue | |||||
Gross Profit | 656 | 650 | 609 | 641 | 691 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 981 | 874 | 794 | 807 | 837 |
Operating Profit | -71.6 | 17.6 | 37.1 | 48.6 | 77.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -92.9 | 1.92 | 22.3 | 42.9 | 68.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -73.3 | -2.75 | 19.4 | 35.9 | 59.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -73.3 | -2.75 | 19.4 | 35.9 | 59.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -73.3 | -2.75 | 19.4 | 35.9 | 59.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.407 | -0.021 | 0.7 | 0.873 | 1.27 |